Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v1-EN
Language French English
Date Updated 2019-01-17 2018-12-12
Drug Identification Number 00784400 00784400
Brand name APO-AMILZIDE TAB APO-AMILZIDE TAB
Common or Proper name AMILZIDE AMILZIDE
Company Name AA PHARMA INC AA PHARMA INC
Ingredients HYDROCHLOROTHIAZIDE AMILORIDE HYDROCHLORIDE HYDROCHLOROTHIAZIDE AMILORIDE HYDROCHLORIDE
Strength(s) 50MG 5MG 50MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 1000 BTL 1000 BTL
ATC code C03EA C03EA
ATC description DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-12-10 2018-12-10
Actual start date 2018-12-10
Estimated end date 2019-01-18 2019-01-02
Actual end date 2019-01-14
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments